Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0220723 (
PCA
)
4,687
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The synthesis and structure-activity relationships of a number of 1,3-bis(aryloxy)propanes, which are in vivo antagonists of LTD4 in the guinea pig, are described. One of these compounds, 4 (Wy-44,329), was not only approximately equipotent with the standard 1 (FPL 55712) in the
LTC4
(ID50 = 0.17 and 0.23 mg/kg iv, respectively) and LTD4 (ID50 = 0.11 and 0.15 mg/kg iv, respectively) challenge models but also possessed greater potency in the ovalbumin challenge model (ID50 = 0.47 mg/kg and 4.1 mg/kg iv, respectively) and a longer duration of action. This compound was a competitive LTD4 antagonist on guinea pig ileum (pA2 = 9.4) and possessed mediator release (rat
PCA
, ID50 = 0.26 mg/kg iv) and 5-lipoxygenase (IC50 = 32 microM vs. 5-HETE) inhibitory activities.
...
PMID:Novel 1,3-bis(aryloxy)propanes as leukotriene D4 antagonists. 380 66
Eight kinds of kampo medicines mainly used for the treatment of asthma and other respiratory diseases, whose comparative effects were still unproven, were selected for comparison of their antiallergic activity in the present study. 1) In an experiment on 48-hr
PCA
reaction in rats passively sensitized with anti egg albumin IgE antisera, inhibitory effects were observed in those groups orally administered with the tested kampo medicines. Among the drugs tested, TJ-19 showed a potent inhibitory activity as effective as that of tranilast (TL). 2) In the study of extraction method, the effects of kampo drugs varied widely according to the extraction method by which they were prepared. This suggests that the routine methods for preparing these extracts should be reconsidered to achieve the optimal efficacy. 3) In the study of histamine release from rat peritoneal cells stimulated with compound 48/80, TJ-55, TJ-19 and TL exerted a strong inhibition, but TJ-119, TJ-29 and TJ-96 had a weak inhibition. 4) TJ-96, TJ-19 and TL exerted a strong inhibitory effect on
LTC
, release from rat peritoneal mast cells induced by calcium (Ca) ionophore A23187, but TJ-95, TJ-55 and TJ-119 exerted only a weak inhibition. To sum up of the results, any of these kampo medicines have unique pharmacological action and antiallergic effects. Besides, the method for extraction affects the efficacy of kampo medicine in vitro.
...
PMID:Comparative studies on the antiallergic effects of kampo medicines used for the therapy of respiratory diseases. 759 44